Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeffery F. Miller is active.

Publication


Featured researches published by Jeffery F. Miller.


Cell | 2004

LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response

Sean B. Joseph; Michelle N. Bradley; Antonio Castrillo; Kevin W. Bruhn; Puiying A. Mak; Liming Pei; John B. Hogenesch; Ryan M. O'Connell; Genhong Cheng; Enrique Saez; Jeffery F. Miller; Peter Tontonoz

The liver X receptors (LXRs) are nuclear receptors with established roles in the regulation of lipid metabolism. We now show that LXR signaling not only regulates macrophage cholesterol metabolism but also impacts antimicrobial responses. Mice lacking LXRs are highly susceptible to infection with the intracellular bacteria Listeria monocytogenes (LM). Bone marrow transplant studies point to altered macrophage function as the major determinant of susceptibility. LXR-null macrophages undergo accelerated apoptosis when challenged with LM and exhibit defective bacterial clearance in vivo. These defects result, at least in part, from loss of regulation of the antiapoptotic factor SPalpha, a direct target for regulation by LXRalpha. Expression of LXRalpha or SPalpha in macrophages inhibits apoptosis in the setting of LM infection. Our results demonstrate that LXR-dependent gene expression plays an unexpected role in innate immunity and suggest that common nuclear receptor pathways mediate macrophage responses to modified lipoproteins and intracellular pathogens.


Journal of Immunology | 2005

The TLR7 Agonist Imiquimod Enhances the Anti-Melanoma Effects of a Recombinant Listeria monocytogenes Vaccine

Noah Craft; Kevin W. Bruhn; Bidong D. Nguyen; Robert M. Prins; Jia Wei Lin; Linda M. Liau; Jeffery F. Miller

Activation of innate immune cells through TLR triggers immunomodulating events that enhance cell-mediated immunity, raising the possibility that ligands to these receptors might act as adjuvants in conjunction with T cell activating vaccines. In this report, topical imiquimod, a synthetic TLR7 agonist, significantly enhanced the protective antitumor effects of a live, recombinant listeria vaccine against murine melanoma. This tumor protective effect was not dependent on direct application to the tumor and was associated with an increase in tumor-associated and splenic dendritic cells. Additionally, the combination of imiquimod treatment with prior vaccination led to development of localized vitiligo. These findings indicate that activation of the innate immune system with TLR ligands stimulates dendritic cell activity resulting in a bypass of peripheral tolerance and enhanced antitumor activity. The results of these studies have broad implications for future designs of immunotherapeutic vaccines against tumors and the treatment of metastatic melanoma.


Science | 2012

Adaptations of avian flu virus are a cause for concern

Kenneth I. Berns; Arturo Casadevall; Murray L. Cohen; Susan A. Ehrlich; Lynn W. Enquist; J. Patrick Fitch; David R. Franz; Claire M. Fraser-Liggett; Christine M. Grant; Michael J. Imperiale; Joseph Kanabrocki; Paul Keim; Stanley M. Lemon; Stuart B. Levy; John R. Lumpkin; Jeffery F. Miller; Randall S. Murch; Mark E. Nance; Michael T. Osterholm; David A. Relman; James A. Roth; Anne K. Vidaver

Members of the National Science Advisory Board for Biosecurity explain its recommendations on the communication of experimental work on H5N1 influenza. We are in the midst of a revolutionary period in the life sciences. Technological capabilities have dramatically expanded, we have a much improved understanding of the complex biology of selected microorganisms, and we have a much improved ability to manipulate microbial genomes. With this has come unprecedented potential for better control of infectious diseases and significant societal benefit. However, there is also a growing risk that the same science will be deliberately misused and that the consequences could be catastrophic. Efforts to describe or define life-sciences research of particular concern have focused on the possibility that knowledge or products derived from such research, or new technologies, could be directly misapplied with a sufficiently broad scope to affect national or global security. Research that might greatly enhance the harm caused by microbial pathogens has been of special concern (1–3). Until now, these efforts have suffered from a lack of specificity and a paucity of concrete examples of “dual use research of concern” (3). Dual use is defined as research that could be used for good or bad purposes. We are now confronted by a potent, real-world example.


international conference on solid-state sensors, actuators and microsystems | 2011

Photothermal nanoblade for large cargo delivery into mammalian cells

Ting-Hsiang Wu; Tara Teslaa; Sheraz Kalim; Christopher T. French; Shahriar Moghadam; Randolph Wall; Jeffery F. Miller; Owen N. Witte; Michael A. Teitell; Pei-Yu Chiou

We report a photothermal nanoblade that utilizes a metallic nanostructure to harvest laser pulse energy and convert it into a localized explosive vapor bubble, which rapidly punctures a lightly-contacting cell membrane via high-speed fluidic flows and induced transient shear stress. Integrating the metallic nanostructure with a micropipette, the nanoblade generates a micron-sized membrane access port for delivering concentrated cargo (5×108 bacteria/ml) with high efficiency (46%) and cell viability (>90%) into mammalian cells. Additional biologic and inanimate cargo over 3-orders of magnitude in size including DNA, 200 nm polystyrene beads to 2 µm bacteria have been delivered into multiple cell types.


Nature | 2012

Policy: Adaptations of avian flu virus are a cause for concern

Kenneth I. Berns; Arturo Casadevall; Murray L. Cohen; Susan A. Ehrlich; Lynn W. Enquist; J. Patrick Fitch; David R. Franz; Claire M. Fraser-Liggett; Christine M. Grant; Michael J. Imperiale; Joseph Kanabrocki; Paul S. Keim; Stanley M. Lemon; Stuart B. Levy; John R. Lumpkin; Jeffery F. Miller; Randall S. Murch; Mark E. Nance; Michael T. Osterholm; David A. Relman; James A. Roth; Anne K. Vidaver

Members of the US National Science Advisory Board for Biosecurity explain its recommendations on the communication of experimental work on H5N1 influenza.


Applied and Environmental Microbiology | 2012

Fluid Flow Induces Biofilm Formation in Staphylococcus epidermidis Polysaccharide Intracellular Adhesin-positive Clinical Isolates

Westbrook M. Weaver; Vladana Milisavljevic; Jeffery F. Miller; Dino Di Carlo

ABSTRACT Staphylococcus epidermidis is a common cause of catheter-related bloodstream infections, resulting in significant morbidity and mortality and increased hospital costs. The ability to form biofilms plays a crucial role in pathogenesis; however, not all clinical isolates form biofilms under normal in vitro conditions. Strains containing the ica operon can display significant phenotypic variation with respect to polysaccharide intracellular adhesin (PIA)-based biofilm formation, including the induction of biofilms upon environmental stress. Using a parallel microfluidic approach to investigate flow as an environmental signal for S. epidermidis biofilm formation, we demonstrate that fluid shear alone induces PIA-positive biofilms of certain clinical isolates and influences biofilm structure. These findings suggest an important role of the catheter microenvironment, particularly fluid flow, in the establishment of S. epidermidis infections by PIA-dependent biofilm formation.


Journal of Bacteriology | 2006

Species- and Strain-Specific Control of a Complex, Flexible Regulon by Bordetella BvgAS

Craig A. Cummings; H. J. Bootsma; David A. Relman; Jeffery F. Miller


Structure | 2013

Structure of the Essential Diversity-Generating Retroelement Protein bAvd and Its Functionally Important Interaction with Reverse Transcriptase

Maher Alayyoubi; Huatao Guo; Sanghamitra Dey; Talin Golnazarian; Garrett A. Brooks; Andrew Rong; Jeffery F. Miller; Partho Ghosh


Archive | 2006

VACCINE FORMULATIONS FOR LEISHMANIA

Mary E. Wilson; Daniella R.A. Martins; John E. Donelson; Selma M. B. Jeronimo; Kevin W. Bruhn; Noah Craft; Jeffery F. Miller


BMC Structural Biology | 2016

Conservation of the C-type lectin fold for accommodating massive sequence variation in archaeal diversity-generating retroelements

Sumit Handa; Blair G. Paul; Jeffery F. Miller; David L. Valentine; Partho Ghosh

Collaboration


Dive into the Jeffery F. Miller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin W. Bruhn

University of California

View shared research outputs
Top Co-Authors

Avatar

Anne K. Vidaver

University of Nebraska–Lincoln

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Patrick Fitch

Battelle Memorial Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John R. Lumpkin

Robert Wood Johnson Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge